https://carrerasresearch.org/en/publications/the-hsp90-inhibitor-ipi-504-overcomes-bortezomib-resistance-in-mantle-cell-lymphoma-in-vitro-and-in-vivo-by-down-regulation-of-the-prosurvival-er-chaperone-bipgrp78/
The Hsp90 inhibitor IPI-504 overcomes bortezomib resistance in mantle cell lymphoma in vitro and in vivo by down-regulation of the prosurvival ER chaperone BiP/Grp78